Pfizer : PFE

All Pfizer Articles

1533 Articles

Chris Lange | Oct 28, 2018 at 7:20 AM EDT

Apple, Exxon, Pfizer and More Dow Earnings to Watch For

24/7 Wall St. has put together a preview of the Dow companies scheduled to report their quarterly results this week.…

Chris Lange | Oct 25, 2018 at 9:00 AM EDT

Major Pharma Short Sellers Hike Their Bets

The October 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Oct 25, 2018 at 7:10 AM EDT

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices…

Chris Lange | Oct 23, 2018 at 1:15 PM EDT

Pfizer and Bain Capital Partner Up to Tackle CNS Disorders

Pfizer, in collaboration with Bain Capital, announced the creation of Cerevel Therapeutics, a new biopharmaceutical company focused on developing drug…

Paul Ausick | Oct 20, 2018 at 8:55 AM EDT

Apple Again Top-Performing Dow Stock, but Merck Is Closing In

Apple shares dipped again last week, but the company managed to hold onto its rank as the top-performing Dow stock…

Paul Ausick | Oct 14, 2018 at 9:05 AM EDT

9 Dow Components Up by Double Digits

In 2017, 20 of the 30 stocks that comprise the Dow Jones Industrial Average posted double-digit, year-over-year share price gains.…

Paul Ausick | Oct 11, 2018 at 4:01 PM EDT

Chevron, Exxon Hammer the Dow Thursday

For the second consecutive trading day, all 30 Dow stocks closed lower Thursday. Exxon, Chevron, Pfizer, and McDonald's were the…

Chris Lange | Oct 10, 2018 at 9:10 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Oct 1, 2018 at 11:50 AM EDT

Pfizer Announces Big Changes at the Top

Pfizer shares hit multiyear highs and nearly an all-time in Monday’s session after the pharma giant announced a succession plan…

Chris Lange | Sep 26, 2018 at 8:50 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 13, 2018 at 9:55 AM EDT

Short Sellers Back Off Major Pharma Stocks

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 8, 2018 at 7:10 AM EDT

Major Biopharma Catalysts on September’s FDA Calendar

Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food…

Chris Lange | Aug 27, 2018 at 10:05 AM EDT

Pfizer Slips Despite Strong Late-Stage Results

Pfizer shares slipped on Monday despite the company posting positive results from a late-stage tafamidis trial.

Chris Lange | Aug 27, 2018 at 7:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Aug 23, 2018 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm…

1 … 35 36 37 38 39 … 103

Pfizer : PFE

All Pfizer Articles

Apple, Exxon, Pfizer and More Dow Earnings to Watch For

Major Pharma Short Sellers Hike Their Bets

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Pfizer and Bain Capital Partner Up to Tackle CNS Disorders

Apple Again Top-Performing Dow Stock, but Merck Is Closing In

9 Dow Components Up by Double Digits

Chevron, Exxon Hammer the Dow Thursday

Short Sellers Run for Cover From Major Pharma

Pfizer Announces Big Changes at the Top

Short Sellers Grow More Selective on Major Pharma Stocks

Short Sellers Back Off Major Pharma Stocks

Major Biopharma Catalysts on September’s FDA Calendar

Pfizer Slips Despite Strong Late-Stage Results

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

The Hidden Costs of a 55+ Community Nobody Mentions Until After You Move In

AI’s Absurd Spending Boom? Hyperscalers Are Spending 102% of Cloud Revenue on Capex

Adobe Stock Looks Cheap for a Reason. Here’s Why I’m Buying.

The Hidden Costs of a 55+ Community Nobody Mentions Until After You Move In

How a 53-Year-Old Can Turn $465,000 Into a Monthly Paycheck Machine by 63

The Hidden Costs of a 55+ Community Nobody Mentions Until After You Move In

AI’s Absurd Spending Boom? Hyperscalers Are Spending 102% of Cloud Revenue on Capex

Pfizer : PFE

All Pfizer Articles

Apple, Exxon, Pfizer and More Dow Earnings to Watch For

Major Pharma Short Sellers Hike Their Bets

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Pfizer and Bain Capital Partner Up to Tackle CNS Disorders

Apple Again Top-Performing Dow Stock, but Merck Is Closing In

9 Dow Components Up by Double Digits

Chevron, Exxon Hammer the Dow Thursday

Short Sellers Run for Cover From Major Pharma

Pfizer Announces Big Changes at the Top

Short Sellers Grow More Selective on Major Pharma Stocks

Short Sellers Back Off Major Pharma Stocks

Major Biopharma Catalysts on September’s FDA Calendar

Pfizer Slips Despite Strong Late-Stage Results

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

The Hidden Costs of a 55+ Community Nobody Mentions Until After You Move In

AI’s Absurd Spending Boom? Hyperscalers Are Spending 102% of Cloud Revenue on Capex

Adobe Stock Looks Cheap for a Reason. Here’s Why I’m Buying.

Featured Reads

The Hidden Costs of a 55+ Community Nobody Mentions Until After You Move In

How a 53-Year-Old Can Turn $465,000 Into a Monthly Paycheck Machine by 63